Related Experiment Videos
Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis?
1Chlamydia Research Laboratory, Department of Pediatrics, Division of Infectious Diseases, SUNY Health Science Center at Brooklyn, Brooklyn, New York, USA.
Abstract:
We investigated the presence of Chlamydia pneumoniae in 81 normal and pathological specimens obtained from postmortem brain tissues of patients with multiple sclerosis and with other neurological or nonneurological diseases. The assays used included PCR amplification of all DNA samples in the initial study. Culture and a second PCR amplification of the organism in a subset of 19 brain specimens were also performed in two separate laboratories. All results were negative. Thus, this study on a large number of brain tissues suggests that C. pneumoniae is not involved in inflammatory demyelination.
Insights
This study found no evidence of Chlamydia pneumoniae in brain tissues from patients with multiple sclerosis. These findings suggest Chlamydia pneumoniae is not a cause of inflammatory demyelination.
Area of Science:
- Neurology
- Infectious Diseases
- Microbiology
Background:
- Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
- The role of infectious agents, such as Chlamydia pneumoniae, in the pathogenesis of MS remains controversial.
Purpose of the Study:
- To investigate the presence of Chlamydia pneumoniae in postmortem brain tissues from patients with multiple sclerosis and other neurological diseases.
- To determine if Chlamydia pneumoniae is associated with inflammatory demyelination in the brain.
Main Methods:
- Analysis of 81 postmortem brain tissue specimens (normal, MS, other neurological/nonneurological diseases).
- Polymerase Chain Reaction (PCR) amplification of all DNA samples.
- Culture and secondary PCR on a subset of 19 specimens in two independent laboratories.
Main Results:
- All PCR and culture assays for Chlamydia pneumoniae DNA were negative across all tested brain tissue specimens.
- No evidence of Chlamydia pneumoniae infection was detected in any of the brain samples analyzed.
Conclusions:
- The study provides strong evidence against the involvement of Chlamydia pneumoniae in the inflammatory demyelination characteristic of multiple sclerosis.
- These findings do not support the hypothesis that Chlamydia pneumoniae is a causative agent or significant contributor to MS pathogenesis.